Record temperatures and pollution are escalating health risks worldwide. This report highlights the urgent need for integrated climate and health strategies.
FDA rejects Novo Nordisk’s once-weekly insulin after questioning risks
Novo Nordisk’s once-weekly insulin has been turned down by the FDA, and the Danish pharma likely won’t be refiling until next year. The FDA rejection